Pharmaceutical intermediates
Dexmedetomidine Hydrochloride Intermediates
1 pharmaceutical intermediate for Dexmedetomidine Hydrochloride. Indication: Sedation.
About Dexmedetomidine Hydrochloride
- Originator
- Orion Corporation
- Indication
- Sedation
- Approved Date
- 12/17/1999
- DS/DP
- 01/04/2032
Available intermediates
1 intermediate currently listed for Dexmedetomidine Hydrochloride. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 1-Tritylimidazole-4-carboxaldehyde | 33016-47-6 | / | / |
Building toward Dexmedetomidine Hydrochloride?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →